Search Results - "Braun‐Parvez, Laura"
-
1
Breakthrough COVID‐19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients
Published in American journal of transplantation (01-11-2022)“…The cilgavimab−tixagevimab combination retains a partial in vitro neutralizing activity against the current SARS‐CoV‐2 variants of concern (omicron BA.1,…”
Get full text
Journal Article -
2
In‐depth virological assessment of kidney transplant recipients with COVID‐19
Published in American journal of transplantation (01-11-2020)“…Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has spread widely, causing coronavirus disease 2019 (COVID‐19) and significant mortality. However,…”
Get full text
Journal Article -
3
-
4
Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report
Published in BMC nephrology (19-09-2020)“…We here report on the first observation of a C3 mutation that is related to atypical hemolytic and uremic syndrome (aHUS), which occurred in a pancreatic islet…”
Get full text
Journal Article -
5
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
Published in Transplantation (01-08-2023)Get full text
Journal Article -
6
Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients
Published in Transplantation (21-06-2023)Get full text
Journal Article -
7
-
8
Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring
Published in Transplantation (27-06-2013)“…BACKGROUNDOverimmunosuppression is a widely recognized risk factor for BK virus (BKV) infection, particularly with the combination of tacrolimus, mycophenolate…”
Get full text
Journal Article -
9
Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study
Published in Journal of personalized medicine (05-07-2022)“…Kidney transplant recipients (KTRs) displays marked inter-individual variations in magnitude of immune responses to anti-SARS-CoV-2 vaccination. The aim of…”
Get full text
Journal Article -
10
Anti-PLA2R1 antibodies and membranous nephropathy recurrence after kidney transplantation
Published in Kidney international reports (01-09-2024)“…IntroductionMembranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often…”
Get full text
Journal Article -
11
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation
Published in Kidney international reports (01-09-2024)Get full text
Journal Article -
12
Emergency vascular access conversion to native arterio veinous fistula: a prospective study of 37 hemodialysis patients in Rwanda
Published in Néphrologie & thérapeutique (01-11-2014)“…Chronic hemodialysis in Rwanda is relatively recent and most of patients are treated with catheters. Thirty-seven patients who require chronic hemodialysis…”
Get full text
Journal Article -
13
Tenofovir-induced acute renal failure in an HIV patient with normal renal function
Published in Nephrology, dialysis, transplantation (01-02-2005)Get full text
Journal Article -
14
Nephroprotection: how to slow the progression of chronic renal insufficiency?
Published in Néphrologie & thérapeutique (01-05-2005)“…Most nephropathies are characterized by a progression that may result in end-stage renal failure (ESRF). Apart from the specific treatment implemented when…”
Get more information
Journal Article -
15
Conversion des abords vasculaires d’urgence pour hémodialyse en fistules natives au Rwanda : à propos de 37 cas
Published in Néphrologie & thérapeutique (01-11-2014)“…La prise en charge de patients en hémodialyse chronique au Rwanda est récente. L’accès vasculaire utilisé est le plus souvent un cathéter. Trente-sept patients…”
Get full text
Journal Article